Home >> Signaling Pathways >> MAPK Signaling

MAPK Signaling(MAPK信号通路)

Products for  MAPK Signaling

  1. Cat.No. 产品名称 Information
  2. GC10110 PD318088

    5-溴-N-(2,3-二羟基丙氧基)-3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯甲酰胺

    An allosteric inhibitor of MEK1
  3. GC12297 AT7867 A potent and orally bioavailable pan-Akt inhibitor
  4. GC11497 BIRB 796 (Doramapimod)

    达马莫德; BIRB 796

    A potent inhibitor of p38 MAPK
  5. GC18050 Pimasertib (AS-703026)

    N-[(2S)-2,3-二羟基丙基]-3-[(2-氟-4-碘苯基)氨基]-4-吡啶甲酰胺,AS703026; MSC1936369B

    A MEK1/2 inhibitor
  6. GC16835 LY2228820

    5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5-基]-3-(2,2-二甲基丙基)-3H-咪唑并[4,5-B]吡啶-2-胺甲磺酸盐,LY2228820 dimesylate

    A potent inhibitor of p38α MAP kinase
  7. GC13968 SB202190 (FHPI)

    4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑

    SB 202190是一种选择性p38 MAP激酶抑制剂,对p38α和p38β2的IC50分别为50 nM和100 nM。
  8. GC12989 PD184352 (CI-1040)

    2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺,PD 184352

    A potent MEK inhibitor
  9. GC15359 SL-327 A selective MEK1/2 inhibitor
  10. GC10505 GDC-0879

    2,3-二氢-5-[1-(2-羟基乙基)-3-(4-吡啶基)-1H-吡唑-4-基]-1H-茚-1-酮肟

    An inhibitor of B-RafV600E
  11. GC15524 Bumetanide

    布美他尼; Ro 10-6338; PF 1593

    An NKCC1 inhibitor
  12. GC12819 PD98059

    2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮

    D98059是一种有效的选择性MEK抑制剂,IC50为2 μM。
  13. GC17608 Lidocaine

    利多卡因; Lignocaine

    An Analytical Reference Standard
  14. GC15344 SP 600125

    吡唑蒽酮

    SP 600125是一种具有口服活性的、可逆的、具有选择性的ATP竞争性JNK 抑制剂,对JNK1、JNK2和JNK3的IC50分别为40、40和90nM。SP 600125常用于卵巢癌、肿瘤、帕金森病 (PD)、乳腺癌和哮喘的研究。
  15. GC13595 SB 203580

    4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑,SB 203580; RWJ 64809

    SB 203580是p38-MAPK(有丝分裂原活化蛋白激酶)通路的特异性抑制剂。
  16. GC16499 Sorafenib Tosylate

    甲苯磺酸索拉非尼; Bay 43-9006 Tosylate

    A multi-kinase inhibitor
  17. GC17030 AZD6244(Selumetinib)

    司美替尼; AZD6244; ARRY-142886

    A highly selective inhibitor of MEK1/2
  18. GC10111 Regorafenib

    瑞戈非尼; BAY 73-4506

    A multi-kinase inhibitor
  19. GC17455 TAK-632 A selective pan-Raf inhibitor
  20. GC15391 Cercosporamide

    尾孢素酰胺,(-)-Cercosporamide

    A potent inhibitor of fungal Pkc1 and mammalian Mnk isoforms

  21. GC17577 NQDI 1 A selective inhibitor of ASK1
  22. GC10282 Piperlongumine

    荜茇酰胺; Piplartine

    Piperlongumine是从Piper longum L.中提取的天然生物碱化合物,具有多种药理活性,包括抗肿瘤、脂质代谢调节、抗血小板聚集和镇痛活性等。
  23. GC17255 Gliotoxin

    胶霉毒素,Aspergillin

    An immunosuppressive mycotoxin with diverse biological effects
  24. GC11076 XMD8-92

    2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮

    A selective ERK5 inhibitor
  25. GC12691 XMD17-109

    XMD17 109

    A selective ERK5 inhibitor
  26. GC13115 VX-11e

    VX 11e, VX11e

    A selective ERK inhibitor
  27. GC15260 Trametinib DMSO solvate

    曲美替尼二甲亚砜,GSK-1120212 DMSO solvate;Trametinib;JTP-74057;GSK-1120212;GSK1120212;GSK 1120212;JTP 74057;JTP74057

    Trametinib DMSO solvate (GSK-1120212 (DMSO solvate);JTP-74057 (DMSO solvate)) 是一种具有口服活性的 MEK 抑制剂,抑制 MEK1 和 MEK2,IC50 约为 2 nM。 Trametinib DMSO solvate 激活自噬并诱导细胞凋亡。
  28. GC13578 Skepinone-L

    Skepinone L

    An inhibitor of p38 MAPK
  29. GC16001 SCH772984

    (R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺,SCH 772984;SCH-772984

    SCH772984是一种新型的、有效的、ATP竞争性的ERK1和ERK2抑制剂,IC50值分别为4nM和1nM。
  30. GC10054 SB 239063

    反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑,SB-239063;SB239063

    A selective p38 MAPK inhibitor
  31. GC10528 Salirasib

    法尼基硫代水杨酸; S-Farnesylthiosalicylic acid; Farnesyl Thiosalicylic Acid; FTS

    A Ras inhibitor with anti-cancer and anti-atherogenic activity
  32. GC14534 Regorafenib monohydrate

    瑞格非尼一水合物,BAY 73-4506 monohydrate

    A multi-kinase inhibitor
  33. GC14606 Regorafenib hydrochloride

    瑞戈非尼盐酸盐; BAY 73-4506 hydrochloride

    A multi-kinase inhibitor
  34. GC13514 NG25

    N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺,NG 25;NG-25

    An inhibitor of MAP4K2 and TAK1
  35. GC11649 MLN 2480

    6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺,BIIB024, BIIB 024, BIIB-024, MLN2480, MLN 2480, MLN-2480

    An oral pan-Raf kinase inhibitor
  36. GC11277 MEK inhibitor

    (3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-N-甲基-2-氧代-1H-吲哚-6-甲酰胺,1H-Indole-6-carboxamide, 3-[[[3-[(dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-N-methyl-2-oxo-, (3Z)-

    MEK 抑制剂是一种有效的 MEK 抑制剂,具有抗肿瘤效力。
  37. GC13841 JNK-IN-8

    JNK Inhibitor XVI

    JNK-IN-8 是第一个不可逆的JNK抑制剂,作用于JNK1,JNK2和JNK3,具有高度特异性,在A375细胞系中IC50分别为4.7 nM,18.7 nM和1 nM。
  38. GC15028 JNK-IN-7

    3-[[4-(二甲基氨基)-1-氧代-2-丁烯-1-基]氨基]-N-[4-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯基]苯甲酰胺,JNK inhibitor

    A non-selective JNK inhibitor
  39. GC14125 FMK

    fluoromethylketone-pyrrolopyrimidine scaffold

    An inhibitor of RSK2
  40. GC14114 DB07268

    2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺,DB 07268;DB-07268

    A potent inhibitor of JNK1
  41. GC12486 Dabrafenib Mesylate (GSK-2118436)

    甲磺酸达拉非尼; GSK2118436 Mesylate; GSK 2118436B

    A Raf kinase inhibitor
  42. GC14337 Cobimetinib (R-enantiomer)

    考比替尼 (R 型对映体); GDC-0973 R-enantiomer; XL-518 R-enantiomer

    Cobimetinib R-对映异构体是 Cobimetinib 活性较低的 R-对映异构体。 Cobimetinib 是一种有效的选择性 MEK 抑制剂。
  43. GC17426 Cobimetinib (racemate)

    考比替尼 (外消旋体); GDC-0973 racemate; XL518 racemate

    Cobimetinib(消旋体)(GDC-0973 消旋体;XL518 消旋体)是 Cobimetinib 的消旋体。 Cobimetinib 是一种有效的选择性 MEK 抑制剂。
  44. GC10033 Cobimetinib

    考比替尼; GDC-0973; XL518

    A potent, orally available MEK1 inhibitor
  45. GC14693 CMK

    1-[4-氨基-7-(3-羟基丙基)-5-(4-甲基苯基)-7H-吡咯并[2,3-D]嘧啶-6-基]-2-氯乙酮

    CMK 是一种 RSK2 激酶抑制剂,与 FMK 相比,具有相似的效力,但化学稳定性较低。
  46. GC17860 CEP-32496 hydrochloride

    CEP 32496 hydrochloride;CEP32496 hydrochloride

    A potent inhibitor of B-Raf
  47. GC10446 CC-930

    Tanzisertib;CC930;CC 930

    A potent JNK inhibitor
  48. GC14197 CC-401 hydrochloride

    3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑盐酸盐,CC 401;CC401;CC401 HCl

    A potent, specific pan-JNK inhibitor
  49. GC12151 B-Raf inhibitor

    N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-[(6-甲基-7H-吡咯并[2,3-D]嘧啶-4-基)氧基]苯甲酰胺

    B-Raf inhibitor 是一种有效的双重 TGFβ-activated kinase 1 (TAK1) 和 mitogen-activated protein kinase kinase kinase 2 (MAP4K2) 抑制剂,IC50 分别为 41.1 nM 和 18.2 nM。
  50. GC12482 BRAF inhibitor

    N-[2,4-二氟-3-[[5-(3-吡啶基)-1H-吡咯并[2,3-B]吡啶-3-基]羰基]苯基]-2-丙磺酰胺

    BRAF 抑制剂是从专利 WO/2011103196 A1 化合物 P-0850 中提取的 B-Raf 抑制剂。
  51. GC10918 AT7867 dihydrochloride

    4-(4-氯苯基)-4-[4-(1H-吡唑-4-基)苯基]哌啶二盐酸盐,AT-7867 dihydrochloride;AT 7867 dihydrochloride

    A potent and orally bioavailable pan-Akt inhibitor

Items 501 to 550 of 575 total

per page
  1. 8
  2. 9
  3. 10
  4. 11
  5. 12

Set Descending Direction